Contrarily, the treatment of quiescent T4-2 breast cancer cells in a 3D system with TGF-β1 and ECM protein periostin resulted in increased tumor size, indicating that TGF-β1, together with periostin, facilitates the exit from the quiescent state [71]. This evidence concerns the gene TGFB1 and breast cancer.